TRIO PHARMACEUTICALS
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
TRIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-05-25
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.triopharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+1-765-490-0874
Email Addresses:
[email protected]
Total Funding:
3.73 M USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tech Coast Angels
Tech Coast Angels investment in Seed Round - Trio Pharmaceuticals
Newsight Tech Angels
Newsight Tech Angels investment in Seed Round - Trio Pharmaceuticals
Purdue Foundry
Purdue Foundry investment in Seed Round - Trio Pharmaceuticals
SeedFolio
SeedFolio investment in Seed Round - Trio Pharmaceuticals
Friedman BioVentures
Friedman BioVentures investment in Seed Round - Trio Pharmaceuticals
Official Site Inspections
http://www.triopharmaceuticals.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Trio Pharmaceuticals"
TRIO Pharmaceuticals | Cancer Therapeutics
TRIO addresses the above problems by developing a novel class of dual targeting antibody drugs that precisely kills cancer cells, overcomes tumor immunosuppression, and allows the body’s immune system to fight against …See details»
Trio Pharmaceuticals - Crunchbase Company Profile
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current …See details»
TRIO Pharmaceuticals - Overview, News & Similar companies
TRIO Pharmaceuticals contact info: Phone number: (619) 786-3495 Website: www.triopharmaceuticals.com What does TRIO Pharmaceuticals do? Trio Pharmaceuticals, …See details»
TRIO Pharmaceuticals, Inc. | LinkedIn
TRIO Pharmaceuticals, Inc. | 655 followers on LinkedIn. Outsmart Cancer | We are a cancer therapeutics company with a mission to improve efficacy, reduce toxicity and increase …See details»
TRIO PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TRIO PHARMACEUTICALS, INC. of Murrieta, CA. Get the latest business insights from Dun & …See details»
TRIO Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore TRIO Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
TRIO Pharmaceuticals, Inc. - VentureRadar
"Trio Pharmaceuticals, Inc. (TRIO) is a privately held cancer therapeutics company. TRIO is developing first-in-class dual action antibody drug conjugates, TRIObody Drug Conjugate …See details»
TRIO Pharmaceuticals | Cancer Therapeutics
Experience cutting-edge cancer treatment with TRIO Pharmaceuticals. Our dual-action antibody-drug conjugates (ADCs), including TRIObody Drug Conjugates (TDC™), revolutionize therapy …See details»
TRIO Pharmaceuticals - PitchBook
TRIO Pharmaceuticals General Information Description. Developer of a cancer immunotherapeutic antibody drug designed to generate immunogenic tumors. The company's …See details»
Trio Pharmaceuticals - Funding, Financials, Valuation & Investors
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.See details»
TRIO Pharmaceuticals, Inc. | VentureRadar
Website: https://www.triopharmaceuticals.com/ Develops bispecific antibodies and dual-action immunotherapies that target tumor growth and immunosuppression ...See details»
TRIO Pharmaceuticals - Products, Competitors, Financials, …
TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline. Dec 3, 2024. SAN DIEGO--(BUSINESS WIRE)--TRIO Pharmaceuticals, Inc., a …See details»
Trio Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Trio Pharmaceuticals is a company that provides Cancer, Health care and more. Trio Pharmaceuticals is headquartered in US CA. Trio Pharmaceuticals was founded in 2018.See details»
TRIO Pharmaceuticals, Inc. - Overview, Competitors, and
We are a cancer therapeutics company with a mission to improve efficacy, reduce toxicity and increase treatment affordability of cancer drugs.See details»
Trio Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Trio Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Aji Bio-Pharma | Trio Pharmaceuticals, Inc. and Ajinomoto Bio …
More information on TRIO Pharmaceuticals, Inc., contact: Shiva Bhowmik, PhD, CEO [email protected] | (765) 490-0874. About Ajinomoto Bio-Pharma Services …See details»
Purdue Ventures invests in antibody-based cancer therapeutics …
Apr 20, 2023 WEST LAFAYETTE, Ind. — Purdue Ventures, which manages three funds to support Purdue University-connected startups, has invested $250,000 in TRIO …See details»
NuFund Venture Group Invests in TRIO Pharmaceuticals to …
December 3th , 2024– San Diego, CA – NuFund Venture Group (NuFund) is proud to announce its investment in TRIO Pharmaceuticals Inc., a groundbreaking cancer immunotherapeutics …See details»
Trio Medicines
Trio Medicines Ltd (“Trio”) was founded in 2007 by HMR Ltd, London, UK, a contract research organisation, and the late Sir James Black (Nobel Laureate) who invented two classes of …See details»
Trio Pharmaceuticals Raises $2.2 Million Seed
Apr 11, 2023 Trio Pharmaceuticals, Inc. (TRIO) has been bootstrapping the development of its “three arm” approach to treating cancer since its founding – until now. Shiva Bhowmik, …See details»